Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, T-Cell, Peripheral | 5 | 2023 | 134 | 2.480 |
Why?
|
| Lymphoma, T-Cell | 4 | 2023 | 299 | 1.380 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 3 | 2017 | 207 | 1.310 |
Why?
|
| Mucin-1 | 4 | 2017 | 543 | 1.010 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2022 | 84 | 0.800 |
Why?
|
| Azacitidine | 3 | 2023 | 347 | 0.720 |
Why?
|
| Nuclear Physics | 6 | 2014 | 79 | 0.690 |
Why?
|
| Antigens, Differentiation | 1 | 2019 | 927 | 0.560 |
Why?
|
| Receptors, IgG | 1 | 2019 | 582 | 0.550 |
Why?
|
| Hodgkin Disease | 1 | 2022 | 1415 | 0.470 |
Why?
|
| Elementary Particles | 4 | 2014 | 55 | 0.460 |
Why?
|
| Receptors, Immunologic | 1 | 2019 | 1423 | 0.450 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 3557 | 0.450 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 2232 | 0.440 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1378 | 0.410 |
Why?
|
| Depsipeptides | 2 | 2023 | 94 | 0.340 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3086 | 0.330 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2022 | 11524 | 0.330 |
Why?
|
| Models, Theoretical | 6 | 2014 | 3589 | 0.290 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.240 |
Why?
|
| Elementary Particle Interactions | 2 | 2013 | 19 | 0.230 |
Why?
|
| Registries | 1 | 2019 | 8089 | 0.230 |
Why?
|
| Peptides | 1 | 2015 | 4409 | 0.220 |
Why?
|
| Cell Proliferation | 2 | 2017 | 10481 | 0.220 |
Why?
|
| Apoptosis | 2 | 2017 | 9727 | 0.210 |
Why?
|
| Ifosfamide | 1 | 2022 | 228 | 0.210 |
Why?
|
| Cancer Vaccines | 3 | 2019 | 1023 | 0.210 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 5686 | 0.190 |
Why?
|
| Ikaros Transcription Factor | 1 | 2022 | 217 | 0.190 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 16689 | 0.190 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2727 | 0.190 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 2077 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 18029 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 692 | 0.160 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2019 | 3523 | 0.150 |
Why?
|
| Oncogenes | 1 | 2023 | 1265 | 0.150 |
Why?
|
| Mesons | 2 | 2014 | 33 | 0.140 |
Why?
|
| Multiple Myeloma | 3 | 2022 | 5181 | 0.140 |
Why?
|
| Lymphoma, B-Cell | 1 | 2023 | 931 | 0.140 |
Why?
|
| Receptors, Fc | 1 | 2019 | 541 | 0.130 |
Why?
|
| Aminopterin | 1 | 2015 | 15 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2023 | 2969 | 0.120 |
Why?
|
| Flow Cytometry | 2 | 2015 | 5974 | 0.120 |
Why?
|
| NADP | 1 | 2015 | 226 | 0.120 |
Why?
|
| Neutrons | 1 | 2014 | 76 | 0.120 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 10180 | 0.120 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 431 | 0.110 |
Why?
|
| Mice | 7 | 2023 | 81183 | 0.110 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 405 | 0.110 |
Why?
|
| Cell Communication | 2 | 2017 | 1621 | 0.110 |
Why?
|
| Glutathione | 1 | 2015 | 589 | 0.110 |
Why?
|
| Immunologic Factors | 1 | 2022 | 1580 | 0.110 |
Why?
|
| Antigens, Neoplasm | 2 | 2017 | 1988 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 1861 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2187 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 2133 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2017 | 1355 | 0.100 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 13695 | 0.100 |
Why?
|
| Remission Induction | 1 | 2016 | 2386 | 0.100 |
Why?
|
| Necrosis | 1 | 2015 | 1643 | 0.100 |
Why?
|
| Drug Synergism | 1 | 2015 | 1792 | 0.090 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1878 | 0.090 |
Why?
|
| Dendritic Cells | 2 | 2019 | 2725 | 0.090 |
Why?
|
| Mice, SCID | 1 | 2015 | 2716 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1157 | 0.090 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 3586 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2022 | 5172 | 0.090 |
Why?
|
| Coculture Techniques | 3 | 2017 | 1341 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2017 | 1270 | 0.080 |
Why?
|
| Animals | 8 | 2023 | 168757 | 0.080 |
Why?
|
| Humans | 19 | 2023 | 744343 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 6895 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2019 | 4479 | 0.080 |
Why?
|
| Protons | 1 | 2013 | 1127 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2015 | 5179 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 6314 | 0.070 |
Why?
|
| Transfection | 1 | 2015 | 5892 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2017 | 2948 | 0.070 |
Why?
|
| Graft vs Host Disease | 1 | 2018 | 2957 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4149 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2915 | 0.060 |
Why?
|
| Survival Rate | 1 | 2019 | 12788 | 0.060 |
Why?
|
| Vaccination | 1 | 2016 | 3278 | 0.060 |
Why?
|
| Acetyl Coenzyme A | 1 | 2023 | 74 | 0.060 |
Why?
|
| Co-Repressor Proteins | 1 | 2023 | 194 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2023 | 317 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8428 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13033 | 0.040 |
Why?
|
| Glycolysis | 1 | 2023 | 827 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2023 | 1097 | 0.040 |
Why?
|
| Cross-Priming | 1 | 2017 | 82 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2022 | 1012 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39050 | 0.040 |
Why?
|
| Perforin | 1 | 2017 | 168 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2015 | 21746 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2023 | 1783 | 0.040 |
Why?
|
| Virus Activation | 1 | 2019 | 319 | 0.040 |
Why?
|
| Thalidomide | 1 | 2022 | 890 | 0.040 |
Why?
|
| Retroviridae | 1 | 2019 | 914 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 23403 | 0.030 |
Why?
|
| Isoantigens | 1 | 2017 | 567 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 2085 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 1369 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 528 | 0.030 |
Why?
|
| Prednisone | 1 | 2018 | 1574 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 2849 | 0.030 |
Why?
|
| Electrons | 1 | 2014 | 268 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1607 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2014 | 596 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 873 | 0.030 |
Why?
|
| Aged | 3 | 2019 | 163280 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2016 | 973 | 0.030 |
Why?
|
| Female | 4 | 2019 | 380194 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 3002 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 987 | 0.020 |
Why?
|
| Immune System | 1 | 2016 | 805 | 0.020 |
Why?
|
| Middle Aged | 3 | 2019 | 213383 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2017 | 1538 | 0.020 |
Why?
|
| Adult | 3 | 2019 | 214055 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 1836 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2018 | 4776 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2017 | 3206 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2107 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5524 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15226 | 0.020 |
Why?
|
| Male | 3 | 2019 | 350118 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 4286 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2023 | 63114 | 0.010 |
Why?
|
| Gene Expression | 1 | 2017 | 7799 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2023 | 12208 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 2988 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9146 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 25043 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7322 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21827 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2017 | 3752 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11483 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5442 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 40561 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 56430 | 0.010 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(61)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_